Chris Worrall Email
VP US Business Development . Nanoform
Helsinki,
LocationPrimary Email
How to contact Chris Worrall
Join and see Chris's contact info for free!Phone
Current Roles
Employees:
196Revenue:
$39.4MAbout
Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.Nanoform Address
Viikinkaari 4Helsinki, null
FIN